DCI’s executive leaders collectively bring decades of experience in both the business and clinical areas of nephrology. They share a calling to further our not-for-profit, patient-centered mission as we look to the future of kidney care.
Leadership
H. Keith Johnson, MD
Founder | Chairman of the Board
Doug Johnson, MD
Vice Chair of the Board
James Perry
Board Member
Ken Johnson
Board Member
Donovan Schultz
President
Stuart Redpath
Chief Operating Officer
Joe Swearingen, CPA
Chief Financial Officer
Robert Taylor, MD
Chief Medical Officer
Carol Stewart, MSN, RN, CNN
Chief Nursing Officer
Pramen Applasamy
Chief Innovation Officer
Mary Hobeika, RN, MSN, MBA
Chief Strategy Officer | Senior Operations Director
Jack Thompson, JD
General Counsel
Eduardo Lacson, MD
Chief Medical Officer, Clinical Science, Quality and Analytics
Lauren Hollingsworth
Chief Operating Officer, REACH Kidney Care
Leanna Tyshler, MD
Chief Medical Officer, REACH Kidney Care
Clinical Quality Team
“Quality Focused” and “Patient Centered” are two DCI core values that guide every DCI initiative across the continuum of care. Continuous improvement is essential to meeting our mission, and we are committed to maximizing our patients’ well-being while improving outcomes in a safe environment.
At least twice per year, we formally seek input from patients regarding certain aspects of their care and experience in our clinics. These formal surveys give us valuable information about patient experience with their doctors, dialysis center staff, and the dialysis center itself. The patient voice then guides improvement efforts at the clinic level which our guided by the corporate Patient Experience team and local leadership.
In addition, we have a robust and comprehensive quality management program for in-center dialysis, home therapies and hospital services. The program calculates key performance indicators monthly for each modality. Local clinic multi-disciplinary teams meet monthly to review their data and develop strategies for addressing clinical and operational metrics that are not meeting defined goals.
At the corporate level, we employ physicians, nurses, biostatisticians, pharmacists and other subject matter experts to develop tools and resources for our local facility teams that enable them to identify areas of opportunity related to quality and safety in DCI clinics. This team of physician leaders, analysts, and researchers collect and analyze data across our clinics to identify trends, potential disparities, and barriers that may exist to achieving the best possible clinical outcomes for our patients. The conclusions drawn from these analyses are shared with DCI physicians and care teams, our partners in the kidney care community, and in some cases government agencies, to positively influence care decisions and clinical and public policy development.